{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:23:27Z","timestamp":1787289807165,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) has been implicated in the development of several malignancies, but its association with oral cancer (OC) remains uncertain. This meta-analysis aimed to evaluate the association between MetS and the risk of incident OC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, and Web of Science were systematically searched from inception to May 11, 2026. Longitudinal cohort studies comparing the incidence of OC between adults with and without MetS were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled using random-effects models accounting for potential heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four cohort studies comprising 6,370,396 participants and 4,539 incident OC cases were included. One study reported sex-specific estimates, resulting in five datasets for the primary meta-analysis. Overall, MetS was associated with a significantly increased risk of OC (HR: 1.12, 95% CI: 1.04\u20131.20;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.001), with low heterogeneity (I\u00b2 = 8%). Leave-one-out sensitivity analyses yielded consistent results (pooled HRs: 1.08\u20131.16). Subgroup analysis showed no significant difference between men and women (HR: 1.14 vs. 1.02;\n                      <jats:italic>p<\/jats:italic>\n                      for subgroup difference = 0.35). Exploratory analyses indicated that hypertriglyceridemia (HR: 1.07, 95% CI: 1.00\u20131.14;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.04) and hyperglycemia (HR: 1.22, 95% CI: 1.10\u20131.36;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001) were significantly associated with increased OC risk, whereas central obesity, low high-density lipoprotein cholesterol, and hypertension were not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current longitudinal evidence suggests that MetS is associated with a modest but significant increase in the risk of incident OC. Findings for individual MetS components are exploratory and hypothesis-generating.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420261432959.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1919070","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:23:33Z","timestamp":1787286213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic syndrome confers a higher risk of oral cancer: a meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Lijun","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Orthodontics, Sichuan Hospital of Stomatology","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dentistry, Sichuan Hospital of Stomatology","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Orthodontics, Sichuan Hospital of Stomatology","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.jpbs_593_25","article-title":"A narrative review on oral squamous cell carcinoma","volume":"17","author":"Muralidharan","year":"2025","journal-title":"J Pharm Bioallied Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/10732748261453684","article-title":"Survival and pathological outcomes of neoadjuvant chemoimmunotherapy followed by surgery in locally advanced oral squamous cell carcinoma","volume":"33","author":"Wang","year":"2026","journal-title":"Cancer Control"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183156","article-title":"Epidemiology, diagnostics, and therapy of oral cancer\u2014update review","volume":"16","author":"Kijowska","year":"2024","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1186\/s12903-025-07280-9","article-title":"Oral health-related quality of life in oral cancer patients assessed with EORTC instruments: a scoping review","volume":"25","author":"Yim","year":"2025","journal-title":"BMC Oral Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.147708","article-title":"Oral cancer: etiology and risk factors: a review","volume":"12","author":"Kumar","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249160","article-title":"Oral cancer and precancer: a narrative review on the relevance of early diagnosis","volume":"17","author":"Abati","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191610261","article-title":"Commonalities in metabolic reprogramming between tobacco use and oral cancer","volume":"19","author":"Rushing","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13289","article-title":"Diabetes mellitus and oral cancer\/oral potentially Malignant disorders: a systematic review and meta-analysis","volume":"27","author":"Ramos-Garcia","year":"2021","journal-title":"Oral Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/164_2015_12","article-title":"Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms","volume":"233","author":"Ben-Shmuel","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1661603","article-title":"Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches","volume":"12","author":"Hamooya","year":"2025","journal-title":"Front Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","article-title":"The interplay of factors in metabolic syndrome: understanding its roots and complexity","volume":"30","author":"Islam","year":"2024","journal-title":"Mol Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-024-03051-7","article-title":"Epidemiology of metabolic syndrome","volume":"477","author":"Pigeot","year":"2025","journal-title":"Pflugers Arch"},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02884-x","article-title":"Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations","volume":"74","author":"Mili","year":"2021","journal-title":"Endocrine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/mou.0000000000001041","article-title":"Metabolic syndrome, obesity and cancer risk","volume":"32","author":"Belladelli","year":"2022","journal-title":"Curr Opin Urol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101070","article-title":"Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase","volume":"21","author":"Battelli","year":"2019","journal-title":"Redox Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/cej.0000000000000618","article-title":"Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis","volume":"30","author":"Mariani","year":"2021","journal-title":"Eur J Cancer Prev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-03974-y","article-title":"Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis","volume":"36","author":"Shen","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1219827","article-title":"Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112401","article-title":"Influence of metabolic syndrome on cancer risk in HBV carriers: a nationwide population based study using the National Health Insurance Service Database","volume":"10","author":"Choe","year":"2021","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04288-4","article-title":"Association between oral cavity cancer and metabolic syndrome","volume":"149","author":"Choi","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12885-025-13955-x","article-title":"Associations of combined lifestyle and metabolic risks with cancer incidence in the UK biobank study","volume":"25","author":"Lin","year":"2025","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.epi-13-0090","article-title":"Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome","volume":"22","author":"van Kruijsdijk","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.31222\/osf.io\/v7gm2_v1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B28","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version6.2","author":"Higgins","year":"2021"},{"key":"B29","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses\n          \n          \n            \n              Wells\n              GA\n            \n            \n              Shea\n              B\n            \n            \n              O'Connell\n              D\n            \n            \n              Peterson\n              J\n            \n            \n              Welch\n              V\n            \n            \n              Losos\n              M\n            \n          \n          \n          2010"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1191\/026921699666884611","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12874-020-00966-4","article-title":"Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals","volume":"20","author":"Maru\u0161i\u0107","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112802","article-title":"Metabolic syndrome and cancer risk: a bidirectional two-sample Mendelian randomization study","volume":"207","author":"Wang","year":"2025","journal-title":"Exp Gerontol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1201\/b16712-22","article-title":"Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obes (Silver Spring)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14060735","article-title":"Oxidative stress and inflammation: drivers of tumorigenesis and therapeutic opportunities","volume":"14","author":"Wang","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.381","article-title":"Obesity and cancer, a case for insulin signaling","volume":"6","author":"Poloz","year":"2015","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.06.007","article-title":"The proliferating role of insulin and insulin-like growth factors in cancer","volume":"21","author":"Gallagher","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010097","article-title":"The role of adipokines in tumor progression and its association with obesity","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"key":"B41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1515\/oncologie-2024-0157","article-title":"Oxidative stress-mediated epigenetic remodeling, metastatic progression and cell signaling in cancer","volume":"26","author":"Phull","year":"2024","journal-title":"Oncologie"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on\u00a0glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081699","article-title":"Advanced glycation end-products acting as immunomodulators for chronic inflammation, inflammaging and carcinogenesis in patients with diabetes and immune-related diseases","volume":"12","author":"Shen","year":"2024","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s12672-025-03299-0","article-title":"Lipid homeostasis dysregulation in oral cancer drives metabolic reprogramming and offers novel diagnostic and therapeutic opportunities","volume":"16","author":"Liang","year":"2025","journal-title":"Discov Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008788","article-title":"Metabolic syndrome and health-related behaviours associated with pre-oral cancerous lesions among adults aged 20-80 years in Yunlin County, Taiwan: a cross-sectional study","volume":"5","author":"Chang","year":"2015","journal-title":"BMJ Open"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041971","article-title":"Effect of metabolic syndrome on incidence of oral potentially Malignant disorder: a prospective cohort study in Taiwan","volume":"10","author":"Siewchaisakul","year":"2020","journal-title":"BMJ Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.04.011","article-title":"Association between metabolic syndrome and oral pre-malignancy: a community- and population-based study (KCIS No. 28)","volume":"47","author":"Yen","year":"2011","journal-title":"Oral Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/prs.0b013e3181f44abc","article-title":"Observational studies: cohort and case-control studies","volume":"126","author":"Song","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae030","article-title":"Impact of potential case misclassification by administrative diagnostic codes on outcome assessment of observational study for people who inject drugs","volume":"11","author":"Goodman-Meza","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105451","article-title":"Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics","volume":"121","author":"Chamoli","year":"2021","journal-title":"Oral Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1919070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:23:35Z","timestamp":1787286215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1919070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":50,"alternative-id":["10.3389\/fonc.2026.1919070"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1919070","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1919070"}}